STRATA Skin Sciences Inc represents a commitment to providing innovative dermatology solutions. Their corporate philosophy revolves around delivering advanced technologies and products to improve patient outcomes. With a focus on dermatology and aesthetic procedures, STRATA Skin Sciences Inc strives to enhance the quality of life for those dealing with skin conditions. By continuously investing in research and development, they aim to bring cutting-edge solutions to the market. Committed to patient satisfaction, STRATA Skin Sciences Inc aims to be a leader in the dermatology industry, offering effective and reliable treatment options for various skin conditions.

STRATA Skin Sciences Inc is primarily present in the United States and Europe. In the United States, the company has a strong presence in major cities like New York, Los Angeles, and Chicago. Additionally, STRATA Skin Sciences Inc has expanded its operations to various European countries such as Germany, France, Italy, and the United Kingdom. With a global reach, STRATA Skin Sciences Inc aims to provide its innovative dermatology products and services to a wide range of patients and healthcare professionals in these key markets.

STRATA Skin Sciences Inc has achieved several significant milestones. Firstly, the company successfully developed and launched XTRAC, a leading excimer laser technology used for treating psoriasis and other skin conditions. Additionally, STRATA Skin Sciences Inc received FDA clearance for XTRAC in 2000, further strengthening its position in the market. The company also expanded its presence globally by entering into strategic partnerships and distribution agreements to enhance the accessibility of its products. Moreover, STRATA Skin Sciences Inc achieved ISO 13485:2016 certification, demonstrating its commitment to quality and compliance in the medical device industry. These milestones showcase the company's dedication to advancing dermatology treatments and its continued growth in the healthcare sector.

STRATA Skin Sciences Inc, previously known as MELA Sciences Inc, is a leading medical technology company specializing in dermatology and skin care products. Established in 1989, STRATA Skin Sciences has been committed to providing innovative solutions for various skin conditions. The company's flagship product, XTRAC, is a highly effective FDA-cleared excimer laser system used in the treatment of psoriasis and vitiligo. With a strong focus on research and development, STRATA Skin Sciences has revolutionized the field of dermatology by introducing cutting-edge technologies and therapies. Today, the company continues to strive towards advancing skin health and improving patients' lives.

The main competitors of STRATA Skin Sciences Inc in the market include companies such as Galderma Laboratories, Lumenis Ltd, and Cutera Inc.

STRATA Skin Sciences Inc is primarily active in the medical technology industry, specifically focused on developing and commercializing innovative solutions for dermatology and aesthetics.

The business model of STRATA Skin Sciences Inc focuses on providing innovative medical devices and solutions for various dermatological conditions. They develop and market advanced technologies, including the XTRAC Excimer Laser and the STRATAPEN MicroSystem, designed to treat psoriasis, vitiligo, and other skin disorders. STRATA Skin Sciences Inc's business strategy revolves around leveraging its scientific expertise to enhance patient outcomes and expand market reach through a combination of direct sales, partnerships, and international distribution networks. With their commitment to advancing dermatology and delivering effective solutions, STRATA Skin Sciences Inc aims to address the medical needs of patients worldwide.

Poměr STRATA Skin Sciences P/E je -1,14.

Koeficient STRATA Skin Sciences tržních hodnot je 0,30.

AlleAktien kvalitní skóre pro STRATA Skin Sciences je 4/10.

očekávané STRATA Skin Sciences obrat je 31,90 mil. USD.

očekávané STRATA Skin Sciences zisk je -8,30 mil. USD.

STRATA Skin Sciences Inc is an innovative company specialized in developing and marketing advanced medical devices for dermatology. They offer a wide range of products and services to assist dermatologists and skincare experts in efficiently and effectively treating and healing skin problems. One of STRATA Skin Sciences' main products is the XTRAC laser therapy. This innovative device uses ultraviolet radiation to treat skin conditions such as psoriasis, vitiligo, and eczema. Its precise application allows affected areas of the skin to be treated quickly without damaging healthy skin, which is not possible with many competitors on the market. The XTRAC laser therapy is undoubtedly one of STRATA Skin Sciences' flagship products, successfully marketed internationally. In addition to the XTRAC laser therapy, STRATA Skin Sciences also offers other technologies for the dermatology industry, such as the STRATAFIX technology used for wound treatment and healing. In addition to these medical devices, the company also provides dermatologists and their patients with access to a wide range of skincare products and creams to care for the skin after treatment. STRATA Skin Sciences has also specialized in telemedicine, which is very convenient for patients. Dermatologists can remotely monitor their patients to minimize the risk of infection in clinics or medical practices. Telemedicine allows specialists to monitor the patient's health and make adjustments to the treatment if necessary. STRATA Skin Sciences' business model is focused on providing a comprehensive range of products and services to meet all the needs of dermatologists and their patients. The company also operates a research and development department to continuously work on developing promising technologies and products to achieve the best possible results for patients. As a leading provider of medical devices for skincare and treatment, STRATA Skin Sciences Inc strives to constantly improve the quality of its products and services. They work closely with top dermatologists and scientists to provide state-of-the-art technologies and products to treat skin problems more effectively and cost-efficiently. Overall, STRATA Skin Sciences is a successful and innovative company dedicated to providing high-quality products and services for healthcare professionals, patients, and the general population. With many years of experience and expertise in dermatology, STRATA Skin Sciences has achieved a leading position in the market, allowing them to continue to grow and provide valuable solutions for treating skin diseases.

STRATA Skin Sciences vyplácí dividendu ve výši 0 USD rozdělenou do výplat během roku.

Dividenda pro STRATA Skin Sciences momentálně nemůže být vypočítána nebo společnost žádnou dividendu nevyplácí.

ISIN společnosti STRATA Skin Sciences je US86272A2069.

WKN společnosti STRATA Skin Sciences je A2DQVU.

Ticker společnosti STRATA Skin Sciences je SSKN.

Během posledních 12 měsíců vyplatila společnost STRATA Skin Sciences dividendu ve výši . To odpovídá dividendovému výnosu přibližně . Pro nadcházejících 12 měsíců se očekává, že STRATA Skin Sciences vyplatí dividendu ve výši 0 USD.

Výnos z dividend společnosti STRATA Skin Sciences aktuálně činí .

STRATA Skin Sciences vyplácí čtvrtletní dividendu. Ta je distribuována v měsících .

STRATA Skin Sciences vyplácela v posledních 0 letech každý rok dividendu.

Očekává se, že v následujících 12 měsících budou dividendy ve výši 0 USD. To odpovídá dividendovému výnosu 0 %.

STRATA Skin Sciences je přiřazen k sektoru 'Zdraví'.

Aby ses mohl podílet na poslední dividendě STRATA Skin Sciences ve výši 0 USD, zaznamenané 3. 10. 2024, měl jsi mít akcii ve svém portfoliu před ex-dnem 3. 10. 2024.

Poslední dividendy byly vyplaceny dne 3. 10. 2024.

V roce 2023 společností STRATA Skin Sciences bylo vyplaceno 0 USD ve formě dividend.

Dividendy společnosti STRATA Skin Sciences jsou vypláceny v USD.